Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application
Sign Up to like & getrecommendations! Published in 2023 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2161671
Abstract: Abstract Amphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous administration in clinical practice. As science continues to move… read more here.
Keywords: administration clinical; potential lipid; administration; strategies amphotericin ... See more keywords